Daniel B. Soland

Daniel B. Soland

DirectoratAcadia Pharmaceuticals· In proxies 2023–2025

Daniel B. Soland sits on 4 public boards.

Boards2

  • Acadia PharmaceuticalsDirector · 8 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
  • DBV TechnologiesDirector · 8 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Acadia PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +33%
  2. DBV TechnologiesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Kalvista Pharmaceuticals, Inc.Public company · 3 yr
    • Director2019 – 2022 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?